Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical is a key manufacturing and research subsidiary of the Sunflower Pharmaceutical Group, located in Jiamusi, Heilongjiang Province, China. The company specializes in the production of Traditional Chinese Medicines (TCM) and chemical pharmaceuticals, with a dominant market presence in pediatric and respiratory health. It operates large-scale, GMP-certified facilities that produce several of the group's flagship products, including the widely recognized Xiao Er Fei Re Ke Chuan Kou Fu Ye for pediatric respiratory conditions. As a core component of one of China's leading pharmaceutical brands, the Jiamusi unit integrates traditional herbal expertise with modern manufacturing standards to serve both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical.